Advocacy Actions
Comments to China Food and Drug Administration (CFDA) on Detailed Regulations on the Examination of Production Licensing of Food for Special Medical Purpose
The European Chamber submitted collated comments to China Food and Drug Administration (CFDA) on Detailed Regulations on the Examination of Production Licensing of Food for Special Medical Purpose.
Read moreMeeting with Vice Administrator of the CAAC
President Wuttke led a delegation and had a meeting with Vice Administrator Wang Zhiqing of the Civil Aviation Administration of China, CAAC.
Read moreMeeting with Italian President S.E. Sergio Mattarella
Meeting with Italian president S.E. Sergio Mattarella during his visit in Shanghai.
Read moreMeeting with Shenzhen HFPC on Bundled Hospital Payment
The Healthcare Equipment Working Group met with the Vice Director of the Health and Family Planning Commission of Shenzhen Municipality (Shenzhen HFPC) to discuss the effects of the recently introduced bundled payment of medical services at Shenzhen hospitals.
Read moreMeeting with the Italian President S.E. Sergio Mattarella
Met Italian President and introduced him our Chamber and our work.
Read moreLobby Letter to CFDA on Drug Renaming and Impact on Reimbursement
Lobby Letter to CFDA on Drug Renaming and Impact on Reimbursement
Read moreMeeting with Vice President of Zhejiang Institute of Standardization on Future Cooperation
European Chamber Shanghai Chapter met with Vice President of Zhejiang Institute of Standardization on future cooperation.
Read moreComments to China Food and Drug Administration (CFDA) on Technical Guidelines for Labeling Specification in the Registration of Recipes of Infant and Young Children Formula (Trial Edition)
The European Chamber submitted collated comments to China Food and Drug Administration (CFDA) on Technical Guidelines for Labeling Specification in the Registration of Recipes of Infant and Young Children Formula (Trial Edition).
Read moreComments to China Food and Drug Administration (CFDA) on Technical Guidelines for the Stability Study in Formula Registration of Infant Formula Milk Powder (Trial Edition)
The European Chamber submitted collated comments to China Food and Drug Administration (CFDA) on Technical Guidelines for the Stability Study in Formula Registration of Infant Formula Milk Powder (Trial Edition) .
Read moreLunch meeting with Deputy Director General Patrick Child (European Commission, DG RTD)
Deputy Director General Patrick Child (European Commission, DG RTD) visited Beijing in February 2017 to prepare the next Innovation Mission with the Chinese counterparts
Read more